(Q37608907)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

review article

1 reference

title

New advances that enable identification of glioblastoma recurrence (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Manish K Aghi

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

6 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

648-657

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19806145%20AND%20SRC:MED&resulttype=core&format=json

Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Reirradiation of primary CNS tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Reirradiation tolerance of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

What drives intense apoptosis resistance and propensity for necrosis in glioblastoma? A role for Bcl2L12 as a multifunctional cell death regulator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Effect of bevacizumab on radiation necrosis of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Diffusion tensor imaging for differentiation of recurrent brain tumor and radiation necrosis after radiotherapy--three case reports.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Postoperative radiotherapy of astrocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Cerebral radiation necrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Interstitial brachytherapy for malignant brain tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Delayed adverse effects after irradiation of gliomas: clinicopathological analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Cancer therapy-associated CNS neuropathology: an update and review of the literature.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Early clinical and neuroradiological worsening after radiotherapy and concomitant temozolomide in patients with glioblastoma: tumour progression or radionecrosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Radiation necrosis or glioma recurrence: is computer-assisted stereotactic biopsy useful?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Mechanisms of radiation injury to the central nervous system: implications for neuroprotection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Capillary loss precedes the cognitive impairment induced by fractionated whole-brain irradiation: a potential rat model of vascular dementia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Vascular damage after fractionated whole-brain irradiation in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Responses of normal cells to ionizing radiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Role of acidic sphingomyelinase in Fas/CD95-mediated cell death.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Ataxia telangiectasia-mutated gene product inhibits DNA damage-induced apoptosis via ceramide synthase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Radiation-induced normal tissue injury: role of adhesion molecules in leukocyte-endothelial cell interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines--a clue to radioresistance?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Vascular endothelial growth factor enhances endothelial cell survival and tumor radioresistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Reversible oedema and necrosis after irradiation of the brain. Diagnostic procedures and clinical manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

MGMT gene silencing and benefit from temozolomide in glioblastoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Bevacizumab plus irinotecan in recurrent glioblastoma multiforme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

VEGF-Trap: a VEGF blocker with potent antitumor effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Scheduling of radiation with angiogenesis inhibitors anginex and Avastin improves therapeutic outcome via vessel normalization.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

MRI in patients with high-grade gliomas treated with bevacizumab and chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Emerging antiangiogenic treatments for gliomas - efficacy and safety issues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Diffusion-weighted magnetic resonance imaging in radiation-induced cerebral necrosis. Apparent diffusion coefficient in lesion components.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Multiparametric tissue characterization of brain neoplasms and their recurrence using pattern classification of MR images

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Comparative follow-up of enhancement phenomena with MRI and Proton MR Spectroscopic Imaging after intralesional immunotherapy in glioblastoma--Report of two exceptional cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2009.150

Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

31 March 2020

1 reference

12 December 2020

Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis.

1 reference

12 December 2020

Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.

1 reference

12 December 2020

Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.

1 reference

12 December 2020

Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumor recurrence.

1 reference

12 December 2020

Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

1 reference

12 December 2020

Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison.

1 reference

12 December 2020

Endothelial apoptosis initiates acute blood-brain barrier disruption after ionizing radiation

1 reference

12 December 2020

Multivoxel magnetic resonance spectroscopy of brain tumors

1 reference

12 December 2020

Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury.

1 reference

12 December 2020